Revisiting the role of histo-blood group antigens in rotavirus host-cell invasion

Nature Communications

Volumn 6, Issue , 2015, Pages

  Böhm, Raphael ^a   Fleming, Fiona E ^b   Maggioni, Andrea ^a   Dang, Vi T ^b   Holloway, Gavan ^b   Coulson, Barbara S ^b   Von Itzstein, Mark ^a   Haselhorst, Thomas ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; EPITOPE; FUCOSE; BLOOD GROUP ABO SYSTEM; OLIGOSACCHARIDE;

ANTIGEN; CELLS AND CELL COMPONENTS; GENOTYPE; PATHOGENICITY; UNCERTAINTY ANALYSIS; VIRUS;

ARTICLE; BLOOD GROUP H TYPE 1 SYSTEM; BLOOD GROUP LEWIS SYSTEM; CARBOHYDRATE ANALYSIS; CELL INVASION; CONTROLLED STUDY; HOST CELL; HUMAN ROTAVIRUS; MOLECULAR DYNAMICS; NONHUMAN; ROTAVIRUS; VIRUS STRAIN; BLOOD GROUP ABO SYSTEM; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; ROTAVIRUS INFECTION; VIRUS ENTRY;

HUMAN ROTAVIRUS A; ROTAVIRUS;

ABO BLOOD-GROUP SYSTEM; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR DYNAMICS SIMULATION; MOLECULAR STRUCTURE; OLIGOSACCHARIDES; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIRUS INTERNALIZATION;

EID: 84938313711     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6907     Document Type: Article

References (68)

1. Tate, J. E. et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect. Dis. 12, 136-141 (2012).
2. Richardson, V. et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N. Engl. J. Med. 362, 299-305 (2010).
3. Weintraub, E. S. et al. Risk of intussusception after monovalent rotavirus vaccination. N. Engl. J. Med. 370, 513-519 (2014).
4. Yih, W. K. et al. Intussusception risk after rotavirus vaccination in U.S. infants. N. Engl. J. Med. 370, 503-512 (2014).
5. Bowen, M. D. & Payne, D. C. Rotavirus vaccine-derived shedding and viral reassortants. Expert Rev. Vaccines 11, 1311-1314 (2012).
6. Banyai, K. et al. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 30(Suppl 1): A122-A130 (2012).
7. Fiore, L., Greenberg, H. B. & Mackow, E. R. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 181, 553-563 (1991).
8. Ciarlet, M. et al. Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J. Virol. 76, 4087-4095 (2002).
9. Guo, C. T. et al. Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J. Biochem. 126, 683-688 (1999).
10. Delorme, C. et al. Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J. Virol. 75, 2276-2287 (2001).
11. Haselhorst, T. et al. Recognition of the GM3 ganglioside glycan by Rhesus rotavirus particles. Angew. Chem. Int. Ed. Engl. 50, 1055-1058 (2011).
12. Haselhorst, T. et al. Sialic acid dependence in rotavirus host cell invasion. Nat. Chem. Biol. 5, 91-93 (2009).
13. Yu, X. et al. Novel structural insights into rotavirus recognition of ganglioside glycan receptors. J. Mol. Biol. 413, 929-939 (2011).
14. Dormitzer, P. R. et al. Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8∗ core. J. Virol. 76, 10512-10517 (2002).
15. Dormitzer, P. R., Sun, Z. Y., Wagner, G. & Harrison, S. C. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 21, 885-897 (2002).
16. Blanchard, H., Yu, X., Coulson, B. S. & von Itzstein, M. Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8∗). J. Mol. Biol. 367, 1215-1226 (2007).
17. Kraschnefski, M. J. et al. Effects on sialic acid recognition of amino acid mutations in the carbohydrate-binding cleft of the rotavirus spike protein. Glycobiology 19, 194-200 (2009).
18. Kraschnefski, M. J. et al. Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the VP8∗ carbohydrate-binding protein of the human rotavirus strain Wa. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 61, 989-993 (2005).
19. Scott, S. A. et al. Crystallization and preliminary X-ray diffraction analysis of the sialic acid-binding domain (VP8∗) of porcine rotavirus strain CRW-8. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 61, 617-620 (2005).
20. Yu, X. et al. Crystallization and preliminary X-ray diffraction analysis of the carbohydrate-recognizing domain (VP8∗) of bovine rotavirus strain NCDV. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 64, 509-511 (2008).
21. Zhang, Y. D., Li, H., Liu, H. & Pan, Y. F. Expression, purification, crystallization and preliminary X-ray diffraction analysis of the VP8∗ sialic acid-binding domain of porcine rotavirus strain OSU. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 63, 93-95 (2007).
22. Fleming, F. E. et al. Relative roles of GM1 ganglioside, N-acylneuraminic acids and α2β1 integrin in mediating rotavirus infection. J. Virol. 88, 4558-4571 (2014).
23. Hu, L. et al. Cell attachment protein VP8∗ of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature 485, 256-259 (2012).
24. Liu, Y. et al. Rotavirus VP8∗: phylogeny, host range, and interaction with histo-blood group antigens. J. Virol. 86, 9899-9910 (2012).
25. Huang, P. et al. Spike protein VP8∗ of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J. Virol. 86, 4833-4843 (2012).
26. Ying, Y. et al. Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses. Mol. Cell Proteomics 13, 2944-2960 (2014).
27. 13C-NMR spectra of four blood-group A active oligosaccharides. Glycoconj. J. 6, 271-284 (1989).
28. Mayer, M. & Meyer, B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123, 6108-6117 (2001).
29. Mayer, M. & Meyer, B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 38, 1784-1788 (1999).
30. Marionneau, S. et al. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83, 565-573 (2001).
31. Huang, P. et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis. 188, 19-31 (2003).
32. Huang, P. et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 79, 6714-6722 (2005).
33. Miura, T. et al. Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses. J. Virol. 87, 9441 (2013).
34. Cao, S. et al. Structural basis for the recognition of blood group trisaccharides by norovirus. J. Virol. 81, 5949-5957 (2007).
35. Choi, J. M., Hutson, A. M., Estes, M. K. & Prasad, B. V. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc. Natl Acad. Sci. USA 105, 9175-9180 (2008).
36. Shanker, S. et al. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J. Virol. 85, 8635-8645 (2011).
37. Chen, Y. et al. Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog. 7, e1002152 (2011).
38. Fiege, B. et al. Molecular details of the recognition of blood group antigens by a human norovirus as determined by STD NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 51, 928-932 (2012).
39. Zierke, M. et al. Stabilization of branched oligosaccharides: Lewis(x) benefits from a nonconventional C-H...O hydrogen bond. J. Am. Chem. Soc. 135, 13464-13472 (2013).
40. McDonald, S. et al. Diversity and relationships of co-circulating modern human rotaviruses revealed using large-scale comparative genomics. J. Virol. 86, 9148-9162 (2012).
41. Nordgren, J. et al. Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype dependent manner. Clin. Infect. Dis. 59, 1567-1573 (2014).
42. Peltier, P., Euzen, R., Daniellou, R., Nugier-Chauvin, C. & Ferrieres, V. Recent knowledge and innovations related to hexofuranosides: structure, synthesis and applications. Carbohydr. Res. 343, 1897-1923 (2008).
43. Meyer, B. & Peters, T. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew. Chem. Int. Ed. Engl. 42, 864-890 (2003).
44. Shuker, S. B., Hajduk, P. J., Meadows, R. P. & Fesik, S. W. Discovering high-affinity ligands for proteins: SAR by NMR. Science 274, 1531-1534 (1996).
45. Graham, K. L. et al. Integrin-using rotaviruses bind α2β1 integrin α2 I domain via VP4 DGE sequence and recognize αXβ2 and αVβ3 by using VP7 during cell entry. J. Virol. 77, 9969-9978 (2003).
46. Ahmed, T. et al. Children with the Le(a + b-) blood group have increased susceptibility to diarrhea caused by enterotoxigenic Escherichia coli expressing colonization factor I group fimbriae. Infect. Immun. 77, 2059-2064 (2009).
47. Yazgan, H. et al. Blood groups and rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 32, 705-706 (2013).
48. Trang, N. V. et al. Association between norovirus and rotavirus Infection and histo-blood group antigen types in Vietnamese children. J. Clin. Microbiol. 52, 1366-1374 (2014).
49. Imbert-Marcille, B. M. et al. A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype. J. Infect. Dis. 209, 1227-1230 (2013).
50. Velazquez, F. R. et al. Rotavirus infections in infants as protection against subsequent infections. N. Engl. J. Med. 335, 1022-1028 (1996).
51. Paul, A., Gladstone, B. P., Mukhopadhya, I. & Kang, G. Rotavirus infections in a community based cohort in Vellore, India. Vaccine 32(Suppl 1): A49-A54 (2014).
52. Jones, M. K. et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science 346, 755-759 (2014).
53. Uchiyama, R. et al. Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J. Infect. Dis. 210, 171-182 (2014).
54. Goto, Y. et al. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345, 1254009 (2014).
55. Pickard, J. M. et al. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 638-641 (2014).
56. Iwamori, M. & Domino, S. E. Tissue-specific loss of fucosylated glycolipids in mice with targeted deletion of α(1,2)fucosyltransferase genes. Biochem. J. 380, 75-81 (2004).
57. Coulson, B. S. et al. Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates. J. Virol. 54, 14-20 (1985).
58. Browning, G. F. et al. Human and bovine serotype G8 rotaviruses may be derived by reassortment. Arch. Virol. 125, 121-128 (1992).
59. van Doorn, L. J. et al. Detection and genotyping of human rotavirus VP4 and VP7 genes by reverse transcriptase PCR and reverse hybridization. J. Clin. Microbiol. 47, 2704-2712 (2009).
60. Rippinger, C. M. Complete genome sequence analysis of candidate human rotavirus vaccine strains RV3 and 116E. Virology 405, 201-213 (2010).
61. Kirkwood, C. D., Bishop, R. F. & Coulson, B. S. Attachment and growth of human rotaviruses RV-3 and S12/85 in Caco-2 cells depend on VP4. J. Virol. 72, 9348-9352 (1998).
62. Krieger, E., Koraimann, G. & Vriend, G. Increasing the precision of comparative models with YASARA NOVA - a self-parameterizing force field. Proteins 47, 393-402 (2002).
63. Tursi, J. M. et al. Production and characterization of neutralizing monoclonal antibody to a human rotavirus strain with a "super-short" RNA pattern. J. Clin. Microbiol. 25, 2426-2427 (1987).
64. Coulson, B. S. & Kirkwood, C. Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. J. Virol. 65, 5968-5974 (1991).
65. Fleming, F. E. et al. Rotavirus-neutralizing antibodies inhibit virus binding to integrins α2β1 and α4β1. Arch. Virol. 152, 1087-1101 (2007).
66. Kirkwood, C. et al. Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites. Arch. Virol. 141, 587-600 (1996).
67. Coulson, B. S. et al. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3. Virology 154, 302-312 (1986).
68. Kiefel, M. J. et al. Synthesis and biological evaluation of N-acetylneuraminic acid-based rotavirus inhibitors. J. Med. Chem. 39, 1314-1320 (1996).